{"ticker": {"uuid": "f6d2f169-da2e-4ad8-ac51-3d191d55c6c3", "symbol": "NANEXA", "name": "Nanexa AB (publ)", "exchange": "STO", "country": "SE", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Bulletin from the Annual General Meeting of Nanexa AB", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOQU56bDNTYTAycWt6Uk9UOEtjQXd5X0NiMXpocFN1UWdsMGtrajgtNVNDTE1jaDFOdE51X1hybXhUdmh1MEZraVVra1pzeHZRM0hOZWhaeFdqanBMb1BfLVczcXQ2UWdldWh0bklfTXlVMy1VQXp1LWJnSXppbUVqV25UYzNtU04wbTkwTGE3X2tDdlFKcFBfM0VQZm0zdTBfTmdLaVZyeFZwUGQ3ajltdkIzbER3RjRQbjQ4?oc=5", "source_name": "TradingView", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nanexa takes semaglutide to the next level \u2013 enabling quarterly dosing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQZ3RCS05waDFvZ19aZktvbkJhOTF3aDZ4bXVTXzRIcWZmYzZDczloWTdNYnVXd1M2NEp5ajhZVFVJdzhuWXo4c2hYQ05LeV8yeWp3RktZNWpEQk81X3VEd2VpdlNYRlZ1Nk05M2NmQ3pHR3JfeDdrNy1VMDI0VnR4OEpzQTZlM01XakNDdG11WEhjMVZMMGU4akpaUFIwZWhJWXc?oc=5", "source_name": "Biostock", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Nanexa AB (OMXSTO:NANEXA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE01VWswV1h5cUpxRE5tVzVMWXZudFA5aHZsMEpKVFFRVEltLUdUVUNLTmVXNXFnNDBPN0xSblVHaTk0TjhJanNNRWVOVEE4U3FZNTd0M3ZLNnFPWTdKMm8zV1lGOW55b2g4S1FUM2hR?oc=5", "source_name": "TradingView", "published_at": "2020-05-31T03:42:05+00:00", "published_display": "31 May 2020 03:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nanexa breaks new ground in drug delivery", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE9VR3hqalpOUnNOUjdpbEM4ZXFuUG1yMVg1OE1xSWlfY3ZuazF6bm5jdElTTjRzYlFKV0NrclR6UUxYbmVWX3UzV3pGTEVGb3hVYTVQOFU5NWlpR29vR1U1aGEza3JuRVQ2Sk5PMVN6VjNzbmkyaHFwUXFlYmE?oc=5", "source_name": "Biostock", "published_at": "2020-02-18T08:00:00+00:00", "published_display": "18 Feb 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Bulletin from the Annual General Meeting of Nanexa AB", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOQU56bDNTYTAycWt6Uk9UOEtjQXd5X0NiMXpocFN1UWdsMGtrajgtNVNDTE1jaDFOdE51X1hybXhUdmh1MEZraVVra1pzeHZRM0hOZWhaeFdqanBMb1BfLVczcXQ2UWdldWh0bklfTXlVMy1VQXp1LWJnSXppbUVqV25UYzNtU04wbTkwTGE3X2tDdlFKcFBfM0VQZm0zdTBfTmdLaVZyeFZwUGQ3ajltdkIzbER3RjRQbjQ4?oc=5", "source_name": "TradingView", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nanexa takes semaglutide to the next level \u2013 enabling quarterly dosing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQZ3RCS05waDFvZ19aZktvbkJhOTF3aDZ4bXVTXzRIcWZmYzZDczloWTdNYnVXd1M2NEp5ajhZVFVJdzhuWXo4c2hYQ05LeV8yeWp3RktZNWpEQk81X3VEd2VpdlNYRlZ1Nk05M2NmQ3pHR3JfeDdrNy1VMDI0VnR4OEpzQTZlM01XakNDdG11WEhjMVZMMGU4akpaUFIwZWhJWXc?oc=5", "source_name": "Biostock", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Nanexa AB (OMXSTO:NANEXA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE01VWswV1h5cUpxRE5tVzVMWXZudFA5aHZsMEpKVFFRVEltLUdUVUNLTmVXNXFnNDBPN0xSblVHaTk0TjhJanNNRWVOVEE4U3FZNTd0M3ZLNnFPWTdKMm8zV1lGOW55b2g4S1FUM2hR?oc=5", "source_name": "TradingView", "published_at": "2020-05-31T03:42:05+00:00", "published_display": "31 May 2020 03:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nanexa breaks new ground in drug delivery", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE9VR3hqalpOUnNOUjdpbEM4ZXFuUG1yMVg1OE1xSWlfY3ZuazF6bm5jdElTTjRzYlFKV0NrclR6UUxYbmVWX3UzV3pGTEVGb3hVYTVQOFU5NWlpR29vR1U1aGEza3JuRVQ2Sk5PMVN6VjNzbmkyaHFwUXFlYmE?oc=5", "source_name": "Biostock", "published_at": "2020-02-18T08:00:00+00:00", "published_display": "18 Feb 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 43, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 2.2, "count": 4}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 3.7, "latest_week": "2026-07-10", "one_week_move": 4.2, "four_week_move": -17.1, "twelve_week_move": -2.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.661829, "market_dynamics_buy_signal": false, "relative_strength": 10.666704, "fair_value_gap": 81.5, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 47.6563, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.2% over one week, -17.1% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 58, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}, {"label": "Biostock", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.2% over one week, -17.1% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Bulletin from the Annual General Meeting of Nanexa AB"}], "updated_at": "2026-07-17T21:25:23.227330+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}